QELBREE 100 mg/1

QELBREE (viloxazine hydrochloride) is an extended-release capsule used for managing certain mental health conditions. This medication is designed to provide sustained relief and is available in a 100 mg strength.

QELBREE is primarily used for the treatment of attention deficit hyperactivity disorder (ADHD) in adults. It works by affecting certain chemicals in the brain that may be unbalanced, helping to improve focus and reduce impulsivity. This medication is part of a broader category of drugs known as selective norepinephrine reuptake inhibitors (SNRIs).

Common effects of QELBREE may include changes in appetite, sleep disturbances, and mild gastrointestinal discomfort. Some users may experience headaches or dizziness, especially when first starting the medication. These effects are generally mild and may diminish over time as the body adjusts to the medication.

QELBREE should be handled with care, stored at room temperature, and kept out of reach of children. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Do not crush or chew the capsules, as they are designed for extended release.

QELBREE may interact with other medications, including those that affect liver enzymes, such as certain antidepressants and antibiotics. It is also advisable to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.